Increasing research and development activities, advancements in genomics, and rising awareness regarding benefits of whole exome sequencing are some key factors expected to drive market growth
Market Dynamics:
Whole exome sequencing is a widely used and important next-generation sequencing technique that efficiently sequences all protein-coding regions in a genome. Whole exome sequencing is primarily used to screen and identify variations and mutations in the protein-coding regions. Whole exome sequencing can accurately detect genetic mutations that are related to birth defects and development delays. Increasing awareness regarding benefits of whole exome sequencing in detecting genetic disorders, rising investment to accelerate genomics and proteomics research, and adoption of cutting-edge technologies are key factors expected to drive market revenue growth over the forecast period.
Whole exome sequencing is a genomic technique that sequences all protein-coding regions in a genome by selecting subset of DNA that encode proteins and then sequencing the exonic DNA through high-throughput DNA sequencing technological. Whole exome sequencing aims to identify genetic variants that alter protein sequences and has been widely used in academic research and as a clinical diagnostic tool. Whole exome sequencing is increasing being used to complement other genetic tests to find mutations in genes known to cause diseases and identify novel genes by comparing exomes from patients with similar attributes. Whole exome sequencing has proven to be an effective tool for discovery of genetic defects in patients having primary immunodeficiencies. It is also an effective tool for molecular diagnosis of rare monogenic disorders, identification of de novo variants in complex diseases, and tumor analysis to identify genes responsible for cancer.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/790
Whole genome sequencing is increasingly cost-effective as compared to whole genome sequencing and is extensively used to identify underlying disease gene mutations to make informed diagnostic and therapeutic decisions and treat at-risk family members. Extensive research is being carried out to understand the application of whole exome sequencing in rare variant gene discovery and this is expected to further drive revenue growth of the market. However, ethical issues associated with this technique, shortage of skilled professionals, and concerns regarding sensitivity of exome sequencing can hamper its adoption and restrain market growth over the forecast period.
COVID-19 Impact Analysis
- The virus outbreak and social distancing norms and restrictions severely disrupted the overall business landscape and operations worldwide.
- COVID-19 pandemic and lockdowns have resulted in several countries shutting down airports, ports, and commercial and domestic transportation. This had impacted manufacturing activities and operations globally and took a toll on the economy of various countries.
- Sudden and drastic downturn in economic activity caused a slowdown in manufacturing, production, import/export, and other sectors and also resulted in employment loss to a major extent.
- Supply impacts were further compounded due to challenges on the demand-side owing to reduced disposable income, depleting savings, and increased concerns and uncertainties.
- Emergence of variants of the virus and rise in infection rates during the initial waves and subsequent lockdowns has severely impacted operations and disrupted supply chains.
Services Segment to Account for Largest Revenue Share:
Services segment to account for largest revenue share over the forecast period owing to increasing demand for high-throughput data analysis services. Data analysis and NGS services cover a wide range of services from experimental design to library generation to help researchers and scientists overcome limitations of bioinformatics-related problems and save time and reduce expenses.
Sequencing by Synthesis to Register Rapid Revenue CAGR:
Sequencing by synthesis is expected to register rapid revenue CAGR over the forecast period owing to increasing adoption of this method for whole exome synthesis attributable to its benefits such as accurate base-by-base sequencing, precise data for various applications, minimal errors, and reduced probability of repeated nucleotides.
Personalized Medicine Segment to Register Significant Revenue Growth:
Personalized medicine segment is expected to dominate other application segments in terms of revenue growth attributable to rising need for customized therapeutic approaches for chronic and rare diseases, rapid progress in genetic medicine, and increasing application of whole exome sequencing in developing advanced diagnostic and therapeutic approaches.
Check Our Prices@ https://www.emergenresearch.com/select-license/790
North America to Account for a Significantly Large Revenue Share:
North America is expected to account for a significantly large revenue share over the forecast period owing to growing focus on personalized medicine, increasing R&D activities in the field of genomics and proteomics, rising application of whole exome sequencing in detection of rare genetic disorders, and robust presence of key market players.
Key Companies in the Market Include:
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies
- Hoffman-La Roche AG
- Eurofins Scientific Group
- GENEWIZ, Inc.
- Knome, Inc.
- Macrogen, Inc.
- Ambry Genetics Corp.
- Beijing Genomics Institute
For the purpose of this report, Emergen Research has segmented the global whole exome sequencing market on the basis of product, application, technology, end-use, and region:
Product Outlook (Revenue, USD Million; 2018-2028)
- Products
- Kits
- DNA Fragmentation End Repair, A-Tailing and Size Selection
- Library Preparation Kits
- Target Enrichment Kits
- Services
- Sequencing Services
- Data Analysis Services
Application Outlook (Revenue, USD Million; 2018-2028)
- Diagnostics
- Cancer
- Monogenic Disorders
- Diabetes
- Others
- Drug Discovery and Development
- Personalized Medicine
- Agriculture and Animal Research
- Others
Technology Outlook (Revenue, USD Million; 2018-2028)
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Others
End-Use Outlook (Revenue, USD Million; 2018-2028)
- Academic Institutions & Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/whole-exome-sequencing-market
Regional Outlook (Revenue, USD Million; 2018-2028)
- North America
- S.
- Canada
- Mexico
- Europe
- K.
- Germany
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
- Rest of MEA
Take a Look at our Related Reports:
Hybrid Operating Room Market Size, Share, Trends, By Component (Surgical Instruments, Audiovisual Display Systems and Tools, Intraoperative Diagnostic Imaging Systems, Operating Room Fixtures), By Application, By End-use, and By Region and Country Forecast to 2028
Healthcare Supply Chain Management Market By Component (Software, Hardware), By Delivery Mode (On-premises Delivery, Cloud-based Delivery), By End-user (Manufacturers, Providers, Distributors), and By Region
Robotics Surgical Simulation Systems Market By Product & Service Type (Conventional Surgery Simulation, Minimally Invasive Surgery Simulation, Others), By Type of Surgery (General Surgery, Endoscopic Surgery, Neurological Surgery, Gynecological Surgery, Cardiac Surgery), By End-use (Hospitals, Surgical Centers, Ambulatory Surgical Centers, Others), and By Region, Forecast to 2028
Ultrasound-Guided Regional Anesthesia Market By Probe (Linear Probe, Curved Array Probe), By Technology (Supraclavicular Block, Interscalene Block, Infraclavicular Block, Axillary Block), By End-use (Hospitals, Ambulatory Surgical Centers), and By Region, Forecast to 2028
In-Situ Hybridization Market By Technology (Fluorescence In-Situ Hybridization, Chromogenic In-Situ Hybridization), By Application (Cancer Diagnostic, Infectious Diseases, and Others), By Product Type (Kits & Reagents, Probes, and Others) By End-use, and By Region, Forecast to 2028
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/industry-report/whole-exome-sequencing-market
